[1]
|
Young, I.S. and Woodside, J.V. (2001) Antioxidants in health and disease. Journal of Clinical Pathology, 54, 176186. doi:10.1136/jcp.54.3.176
|
[2]
|
Change, B., Sies, H. and Baveris, A. (1979) Hydroperoxide metabolism in mammalian organs. Physiological Reviews, 59, 527-605.
|
[3]
|
Yu, B.P. (1994) Cellular defenses from damage from reactive oxygen species. Physiological Reviews, 74, 139-162.
|
[4]
|
Reiter, R.J. (1995) Oxidative processes and antioxidative defense mechanism. FASEB Journal, 9, 526-533.
|
[5]
|
Faraone, S.V., Sergeant, J., Gillberg, C. and Biederman, J. (2003) The worldwide prevalence of ADHD: Is it an American condition? World Psychiatry, 2, 104-113.
|
[6]
|
Biederman, J. and Faraone, S.V. (2005) Attention-deficit hyperactivity disorder. Lancet, 366, 237-248.
doi:10.1016/S0140-6736(05)66915-2
|
[7]
|
Wolraich, M.L., Wibbelsman, C.J., Brown, T.E., Evans, S.W., Gotlieb, E.M., Knight, J.R., et al. (2005) Attentiondeficit/hyperactivity disorder among adolescents: A review of the diagnosis, treatment, and clinical implications. Pediatrics, 115, 1734-1746. doi:10.1542/peds.2004-1959
|
[8]
|
American Psychiatric Association (2005) Diagnostic and statistical manual of mental disorders. American Psychiatric Association, Washington DC.
|
[9]
|
Biederman, J., Petty, C.R., Evans, M., Small, J. and Faraone, S.V. (2010) How persistent is ADHD? A controlled 10-year follow-up study of boys with ADHD. Psychiatry Research, 177, 299-304.
doi:10.1016/j.psychres.2009.12.010
|
[10]
|
Conners, C.K., Epstein, J.N., March, J.S., Angold, A., Wells, K.C., Klaric, J., et al. (2001) Multimodal treatment of ADHD in the MTA: An alternative outcome analysis, Journal of the American Academy of Child & Adolescent Psychiatry, 40, 159-167.
doi:10.1097/00004583-200102000-00010
|
[11]
|
Faraone, S.V., Perlis, R.H., Doyle, A.E., Smoller, J.W., Goralnick, J.J., Holmgren, M.A., et al. (2005) Molecular genetics of attention-deficit/hyperactivity disorder. Biological Psychiatry, 57, 1313-1323.
doi:10.1016/j.biopsych.2004.11.024
|
[12]
|
Khan, S.A. and Faraone, S.V. (2006) The genetics of attention-deficit/hyperactivity disorder: A literature review of 2005. Current Psychiatry Reports, 8, 393-397.
doi:10.1007/s11920-006-0042-y
|
[13]
|
Kaplan, B.J., McNicol, J., Conte, R.A. and Moghadam, H.K. (1989) Dietary replacement in preschool-aged hyperactive boys. Pediatrics, 83, 7-17.
|
[14]
|
Carter, C.M., Urbanowicz, M., Hemsley, R., Mantilla, L., Strobel, S., Graham, P.J., et al. (1993) Effects of a few food diet in attention deficit disorder. Archives of Disease in Childhood, 69, 564-568. doi:10.1136/adc.69.5.564
|
[15]
|
Ross, M.A. (2000) Could oxidative stress be a factor in neurodevelopmental disorders? Prostaglandins, Leukotrienes and Essential Fatty Acids, 63, 61-63.
doi:10.1054/plef.2000.0192
|
[16]
|
Chen, J.R., Hsu, S.F., Hsu, C.D., Hwang, L.H. and Yanget, S.C. (2004) Dietary patterns and blood fatty acid composition in children with attention-deficit hyperactivity disorder in Taiwan. Journal of Nutritional Biochemistry, 15, 467-472. doi:10.1016/j.jnutbio.2004.01.008
|
[17]
|
Young, G.S., Maharaj, N.J. and Conquer, J.A. (2004) Blood phospholipid fatty acid analysis of adults with and without attention deficit/hyperactivity disorder. Lipids, 39, 117-123.
|
[18]
|
Mitchell, E.A., Aman, M.G., Turbott, S.H. and Manku, M. (1987) Clinical characteristics and serum essential fatty acid levels in hyperactive children. Clinical Pediatrics (Phila), 26, 406-411. doi:10.1177/000992288702600805
|
[19]
|
Spahis, S., Vanasse, M., Bélanger, S.A., Ghadirian, P., Grenier, E. and Levy, E. (2008) Lipid profile, fatty acid composition and proand anti-oxidant status in pediatric patients with attention-deficit/hyperactivity disorder. Prostaglandins, Leukotrienes and Essential Fatty Acids, 79, 47-53. doi:10.1016/j.plefa.2008.07.005
|
[20]
|
Masters, C., Pegg, M. and Crane, D. (1986) On the multiplicity of the enzyme in mammalian liver. Molecular and Cellular Biochemistry, 70, 113-120.
doi:10.1007/BF00229426
|
[21]
|
Khurana, S., Corbally, M.T., Manning, F., Armenise, T., Kierce, B. and Kilty, C. (2002) Glutathione S-transferase: A potential new marker of intestinal ischemia. Journal of Pediatric Surgery, 37, 1543-1548.
doi:10.1053/jpsu.2002.36181
|
[22]
|
Awasthi, Y.C., Sharma, R. and Singhal, S.S. (1994) Human glutathione S-transferase. International Journal of Biochemistry, 26, 295-308.
doi:10.1016/0020-711X(94)90050-7
|
[23]
|
American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders DSM-IV. 4th Edition, APA Press, Washington DC.
|
[24]
|
Beers Jr, R.F. and Sizer, I.W. (1952) A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. Journal of Biological Chemistry, 195, 133.
|
[25]
|
Habig, W.H., Pabst, M.J. and Jacob, W.B. (1974) Glutathione S-transferase. The first enzymatic step in mercapturic acid formation. Journal of Biological Chemistry, 249, 7130-7139.
|
[26]
|
Koracevic, D., Koracevic, G., Djordjevic, V., Andrejevic, S. and Cosic, V. (2001) Method for the measurement of antioxidant activity in human fluids. Journal of Clinical Pathology, 54, 356-361. doi:10.1136/jcp.54.5.356
|
[27]
|
Wayner, D.D.M., Burton, G.W., Ingold, K.U., Barclay, L.R.C. and Locke, S.J. (1987) The relative contributions of vitamin E, urate, ascorbate and proteins to the total peroxyl radical-trapping antioxidant activity of human blood plasma. Biochimica et Biophysica Acta, 924, 408419. doi:10.1016/0304-4165(87)90155-3
|
[28]
|
Woodford, F.P. and Whitehead, T.P. (1998) Is measuring serum antioxidant capacity clinically useful? Annals of Clinical Biochemistry, 35, 48-56.
|
[29]
|
Chovanova, Z., Muchova, J., Sivonova, M., Dvorakova, M., Zittnanova, I., Waczulikova, I., et al. (2006) Effect of polyphenolic extract, pycnogenol, on the level of 8oxoguanine in children suffering from attention deficit/ hyperactivity disorder. Free Radical Research, 40, 10031010. doi:10.1080/10715760600824902
|
[30]
|
Joshi, K., Lad, S., Kale, M., Patwardhan, B., Mahadik, S.P., Patni, B., et al. (2006) Supplementation with flax oil and vitamin C improves the outcome of Attention Deficit Hyperactivity Disorder (ADHD). Prostaglandins, Leukotrienes and Essential Fatty Acids, 74, 17-21.
doi:10.1016/j.plefa.2005.10.001
|